Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone ER for Acute Agitation in Psychosis
NCT01050478Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Mar 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paliperidone in psychomotor agitation, sponsored by Johnson & Johnson. Started Mar 2010; status: completed.
02
Drugs
paliperidone
03
Conditions
psychomotor agitation
Beyond the preview
Go deeper on NCT01050478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050478.